Essential Medicines for Children

  title={Essential Medicines for Children},
  author={Kalle Hoppu},
  journal={Clinical Pharmacology \& Therapeutics},
  • K. Hoppu
  • Published 1 June 2017
  • Business, Medicine
  • Clinical Pharmacology & Therapeutics
The World Health Organization (WHO) defines Essential Medicines as those that satisfy the priority healthcare needs of the population. The right to essential medicines has been considered an important component of the right to health. In the name of equity, children should also have access to appropriate, available, affordable, and quality essential medicines they need, but children's essential medicines are too often missing. 

Topics from this paper

Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development
The study recommends policy expansion through a three-pronged approach to improving access: increased supply through facilitated importation/accelerated product registration, or in-country manufacturing; rational drug use including therapeutic substitution, and establishment of a national formulary for compounding.
Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study
Most EMLc medicines for diseases common in the three countries had supporting evidence, which was closely associated with approval, whereas a substantial number of medicines for NIDs were unapproved in theThree countries, regardless of whether they had supportingevidence.
A comparison of five paediatric dosing guidelines for antibiotics
The pharmacokinetic, pharmacodynamic and clinical evidence supporting paediatric antibiotic dosing, particularly on total doses and on age or weight dosing bands, needs to be improved.
Drugs for Children
  • S. Ito
  • Medicine
    Clinical pharmacology and therapeutics
  • 2017
The juncture of pediatric pharmacology and global child health represents an emerging field of clinical pharmacology illuminating a crucial societal need on a global scale for safer and more effective pediatric drug therapy.
Key Challenges in the Search for Innovative Drug Treatments for Special Populations. Converging Needs in Neonatology, Pediatrics, and Medical Genetics
Unless a specific action plan is urgently developed, there will be a continuing gap in availability of the essential expertise needed to address treatment challenges in special patient populations such as neonates, patients suffering from rare or neglected diseases, and children of all ages.
Drug Prescribing Patterns at Public Health Centres in Greater Wad Medani Locality, Gezira State, Sudan (2015)
Prescribing from essential drug list and prescribing by generic names need to be encouraged and clear criteria to control antibiotic prescription are needed.
Children's palliative care in low- and middle-income countries
It is concluded that while much has been achieved in palliative care for adults, less attention has been devoted to the education, clinical practice, funding and research needed to ensure children and young people receive the palliatives care they need.
Improving Availability of Pediatric Formulations
  • S. Bavdekar
  • Medicine
    The Indian Journal of Pediatrics
  • 2021
The authors have stated that nonavailability of medicines in the market despite being listed in EMLs, and lack of demand from clinicians for specific and appropriate formulations contribute to their nonavailability.
Women, children, and global public health: beyond the millennium development goals
As the deadline approaches for the millennium development goals, Nick Brown, Martin Ward Platt, and Mark Beattie discuss the sustainable development goals and the potential barriers to achieving them
Respiratory tract infections in pediatrics: difficult answers to simple questions
This paper responds to seemingly simple questions about RTIs, the use of antibiotics for acute RTIs to prevent bacterial complications, and optimal antibacterial treatment duration in children.


Essential medicines for children
Data from country surveys show that access to essential medicines for children is still generally poor; much more work is needed.
World Health Organization Program for the Selection and Use of Essential Medicines
With all societies dealing with the rising cost of medical care and having to make choices, the concept of essential medicines is a relevant to all now as it was to countries with limited resources when the WHO program started in 1975.
Essential medicines for universal health coverage
10-year Report to the European Commission. General report on the experience acquired as a result of the application of the Paediatric Regulation
  • European Medicines Agency and its Paediatric Committee